Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor

Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oxf Med Case Reports
Egile Nagusiak: Gurbani, Saumya S, Weinberg, Brent D, Salgado, Eric, Voloschin, Alfredo, Velazquez Vega, Jose Enrique, Olson, Jeffrey J, Shu, Hui-Kuo G, Shim, Hyunsuk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104214/
https://ncbi.nlm.nih.gov/pubmed/32257248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak